Carotid stenting: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (10 intermediate revisions by the same user not shown) | |||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
'''Carotid stenting''' (CAS) is a percutaneous, endovascular procedure available to correct [[carotid stenosis]] (narrowing of the [[carotid artery]] lumen by [[atheroma]]). Carotid stenosis can present with no symptoms (diagnosed incidentally) or through symptoms such as [[transient ischemic attack]]s (TIAs) or [[cerebrovascular accident]]s (CVAs, strokes). In a number of clinical trials, in patients at increased for carotid surgery, the rates of 30 day stroke and death have been noninferior or as good as the standard approach, carotid endarterectomy. Over 14,000 patients have been enrolled in trials to evaluate the results of carotid stenting in patients at increased-risk for surgery. High-risk characteristics include anatomical or medical co-morbid conditions. The most significant study to date has been the SAPPHIRE study, which in a randomized controlled study showed carotid stenting to be "noninferior" to endarterectomy in total Major Adverse Event rates, but superior in rates of major procedural stroke, cranial nerve palsy, and myocardial infarction. | '''Carotid stenting''' (CAS) is a percutaneous, endovascular procedure available to correct [[carotid stenosis]] (narrowing of the [[carotid artery]] lumen by [[atheroma]]). Carotid stenosis can present with no symptoms (diagnosed incidentally) or through symptoms such as [[transient ischemic attack]]s (TIAs) or [[cerebrovascular accident]]s (CVAs, strokes). | ||
==Landmark Studies== | |||
In a number of clinical trials, in patients at increased for carotid surgery, the rates of 30 day stroke and death have been noninferior or as good as the standard approach, carotid endarterectomy. Over 14,000 patients have been enrolled in trials to evaluate the results of carotid stenting in patients at increased-risk for surgery. High-risk characteristics include anatomical or medical co-morbid conditions. The most significant study to date has been the SAPPHIRE study, which in a randomized controlled study showed carotid stenting to be "noninferior" to endarterectomy in total Major Adverse Event rates, but superior in rates of major procedural stroke, cranial nerve palsy, and myocardial infarction. <ref>Yadav et. al."Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients". New England Journal of Medicine. October7, 2004. pp1493-1501.</ref> | |||
The question of carotid stenting in non-hi-risk patients has yet to be answered, with a few trials ongoing, including the ''Carotid Revsacularization Endarterectomy versus Stenting Trial'' ('''CREST''')[http://www.cresttrial.org/] funded by the [[National Institutes of Health]] (NIH.) | The question of carotid stenting in non-hi-risk patients has yet to be answered, with a few trials ongoing, including the ''Carotid Revsacularization Endarterectomy versus Stenting Trial'' ('''CREST''')[http://www.cresttrial.org/] funded by the [[National Institutes of Health]] (NIH.) | ||
==Indications== | ==Indications== | ||
| Line 29: | Line 17: | ||
Carotid stenting is currently indicated for the following patients: | Carotid stenting is currently indicated for the following patients: | ||
Either | |||
* Symptomatic patients with >50% stenosis | |||
OR | |||
* | * Asymptomatic patients with >80% stenosis | ||
** [[Congestive Heart Failure]] (Class III/IV), and/or known severe [[left ventricular dysfunction]] ≤30% | |||
AND | |||
* At least one anatomic or co-morbid risk factor placing them at high-risk for adverse events from CEA: | |||
:'''Anatomic Risk Factors:''' | |||
:* Contralateral carotid artery occlusion | |||
:* Contralateral [[laryngeal nerve palsy]] | |||
:* Scarring of the neck post radiation therapy or following neck surgery | |||
:* Recurrent stenosis after prior carotid surgery | |||
:* High cervical carotid artery lesions | |||
:* Carotid artery stenosis: | |||
:** Below the clavicle | |||
:** Distal to the second cervical vertebra | |||
:** Proximal (intrathoracic) arterial stenosis | |||
:* Previous [[carotid endarterectomy]] | |||
:* Contralateral vocal cord paralysis | |||
:* [[Tracheostomy|Open tracheostomy]] | |||
:'''Co-Morbid Conditions:''' | |||
:* [[Congestive Heart Failure]] (Class III/IV), and/or known severe [[left ventricular dysfunction]] ≤30% | |||
:* [[Open-heart surgery]] needed within 6 weeks | |||
:* Recent myocardial infarction (>24 hours and <4 weeks) | |||
:* [[Unstable angina]] (CCS class III/IV) | |||
:* Synchronous severe cardiac and carotid disease requiring open heart surgery and carotid revascularization | |||
:* Severe pulmonary disease to include any of the following: | |||
:** Chronic oxygen therapy | |||
:** Resting P02 of < 60 mmHg | |||
:** Baseline hematocrit > 50% | |||
:** [[FEV1]] or [[DLCO]] < 50% of normal | |||
:* Abnormal [[stress test]] | |||
:* Age greater than 80 years | |||
====Carotid Revascularization in Patients Undergoing CABG==== | ====Carotid Revascularization in Patients Undergoing CABG==== | ||
| Line 69: | Line 61: | ||
The safety and efficacy of carotid revascularization before or concurrent with myocardial revacularization are not well established (II b, C)<ref name="circulation">ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline.Circulation.2011;124:e54-e130</ref>. | The safety and efficacy of carotid revascularization before or concurrent with myocardial revacularization are not well established (II b, C)<ref name="circulation">ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline.Circulation.2011;124:e54-e130</ref>. | ||
== | ==Risk Stratification== | ||
Lesion Characteristics | ===High Risk Lesion Characteristics=== | ||
*Evidence of intraluminal thrombus thought to increase the risk of plaque fragmentation and distal embolization | |||
*Lesion(s) that may require more than two stents | |||
*Very tortuous lesions | |||
*Total occlusion of the target vessel | |||
*Lesions of the ostium of the common carotid | |||
*Highly calcified lesions resistant to balloon inflation | |||
Concurrent treatment of bilateral lesions | *Concurrent treatment of bilateral lesions | ||
Access Characteristics | ===High Risk Access Characteristics=== | ||
Patients with known peripheral vascular, supra-aortic or internal carotid artery tortuosity that would preclude the use of catheter-based techniques. | *Patients with known peripheral vascular, supra-aortic or internal carotid artery tortuosity that would preclude the use of catheter-based techniques. | ||
Patients in whom femoral or brachial access is not possible | *Patients in whom femoral or brachial access is not possible | ||
Patient Characteristics | ===High Risk Patient Characteristics=== | ||
Patients at low-to-moderate risk for adverse events from carotid endarterectomy. | *Patients at low-to-moderate risk for adverse events from carotid endarterectomy. | ||
Patients experiencing acute ischemic neurologic stroke or who experienced a stroke within 48 hours. | *Patients experiencing acute ischemic neurologic stroke or who experienced a stroke within 48 hours. | ||
Patients with an intracranial mass lesion (i.e., abscess, tumor, or infection) or aneurysm (>9mm). | *Patients with an intracranial mass lesion (i.e., abscess, tumor, or infection) or aneurysm (>9mm). | ||
Patients with arterio-venous malformations of the territory of the target carotid artery. | *Patients with arterio-venous malformations of the territory of the target carotid artery. | ||
Patients with coagulopathies. | *Patients with coagulopathies. | ||
Patients with poor renal function, who, in the physician’s opinion, may be at high-risk for a reaction to contrast medium. | *Patients with poor renal function, who, in the physician’s opinion, may be at high-risk for a reaction to contrast medium. | ||
Patients with perforated vessels evidenced by extravasation of contrast media. | *Patients with perforated vessels evidenced by extravasation of contrast media. | ||
Patients with aneurysmal dilation immediately proximal or distal to the lesion. | *Patients with aneurysmal dilation immediately proximal or distal to the lesion. | ||
Pregnant patients or patients under the age of 18. | *Pregnant patients or patients under the age of 18. | ||
==Stenting (CAS) vs Carotid Endarterectomy (CEA)== | ==Stenting (CAS) vs Carotid Endarterectomy (CEA)== | ||
===Outcomes=== | |||
* The CREST study showed a higher rate of death/MI in patients treated with stenting vs CEA: 6.4% vs 4.7%. | * The CREST study showed a higher rate of death/MI in patients treated with stenting vs CEA: 6.4% vs 4.7%. | ||
===Scenarios Where Carotid Endarterectomy is Preferred=== | |||
Carotid endarterectomy is preferred in the setting of: | |||
* | *Impaired renal function with increased risk of [[contrast induced nephropathy]] | ||
**Arterial stenosis distal to the second cervical vertebra or proximal (intrathoracic) arterial stenosis | *A tortuous calcified aortoa | ||
*Complex, eccentric, calcified lesions | |||
===Scenarios Where Carotid Endarterectomy is Preferred=== | |||
* | Carotid endarterectomy is preferred in the setting of: | ||
* | *Neck anatomy unfavorable for arterial surgery(II a, B) | ||
*High carotid bifurcations where it is hard for surgeons to technically perform the surgery. | |||
*Arterial stenosis distal to the second cervical vertebra or proximal (intrathoracic) arterial stenosis | |||
*Previous ipsilateral [[carotid endarterectomy]] [[CEA]] | |||
*Contralateral [[vocal cord paralysis]] | |||
*Open tracheostomy | |||
*History of previous radical neck surgery | |||
*History of [[radiation therapy]]<ref name="circulation">ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline.Circulation.2011;124:e54-e130</ref> | |||
;Shown below is a table comparing carotid endarterectomy versus stenting in symptomatic and asymptomatic patients<ref name="circulation">ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline.Circulation.2011;124:e54-e130</ref> | ;Shown below is a table comparing carotid endarterectomy versus stenting in symptomatic and asymptomatic patients:<ref name="circulation">ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline.Circulation.2011;124:e54-e130</ref> | ||
<center> | |||
{| border="1" cellpadding="10" style="text-align:center" | {| border="1" cellpadding="10" style="text-align:center" | ||
|- | |- | ||
| Line 122: | Line 123: | ||
|'''LOE'''||B||B||B | |'''LOE'''||B||B||B | ||
|} | |} | ||
</center> | |||
==Procedure== | |||
*[[Informed consent]] obtained and [[local anaesthetic]] administered | |||
*Preparation of both groins with antiseptic and draped | |||
*Puncture into [[femoral artery]] and access through short sheath | |||
*[[Guidewire]] passed through [[aorta]] and into arch | |||
*Arch aortogram obtained if not previously performed to confirm suitability to continue | |||
*Carotid and cerebral angiogram performed | |||
*Long access sheath placed after cannulation of common carotid artery (CCA) | |||
*Guidewire passed through area of carotid narrowing | |||
*Placement of embolic protection device above the area of narrowing | |||
*[[Angioplasty]] of carotid narrowing, but more commonly proceed straight to deployment of stent into area of narrowing | |||
*Angioplasty post stent deployment | |||
*Removal of protection device, guidewires and sheath | |||
*Aftercare of groin puncture site | |||
==External links== | ==External links== | ||
Latest revision as of 22:33, 1 November 2012
|
WikiDoc Resources for Carotid stenting |
|
Articles |
|---|
|
Most recent articles on Carotid stenting Most cited articles on Carotid stenting |
|
Media |
|
Powerpoint slides on Carotid stenting |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Carotid stenting at Clinical Trials.gov Trial results on Carotid stenting Clinical Trials on Carotid stenting at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Carotid stenting NICE Guidance on Carotid stenting
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Carotid stenting Discussion groups on Carotid stenting Patient Handouts on Carotid stenting Directions to Hospitals Treating Carotid stenting Risk calculators and risk factors for Carotid stenting
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Carotid stenting |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Carotid stenting (CAS) is a percutaneous, endovascular procedure available to correct carotid stenosis (narrowing of the carotid artery lumen by atheroma). Carotid stenosis can present with no symptoms (diagnosed incidentally) or through symptoms such as transient ischemic attacks (TIAs) or cerebrovascular accidents (CVAs, strokes).
Landmark Studies
In a number of clinical trials, in patients at increased for carotid surgery, the rates of 30 day stroke and death have been noninferior or as good as the standard approach, carotid endarterectomy. Over 14,000 patients have been enrolled in trials to evaluate the results of carotid stenting in patients at increased-risk for surgery. High-risk characteristics include anatomical or medical co-morbid conditions. The most significant study to date has been the SAPPHIRE study, which in a randomized controlled study showed carotid stenting to be "noninferior" to endarterectomy in total Major Adverse Event rates, but superior in rates of major procedural stroke, cranial nerve palsy, and myocardial infarction. [1]
The question of carotid stenting in non-hi-risk patients has yet to be answered, with a few trials ongoing, including the Carotid Revsacularization Endarterectomy versus Stenting Trial (CREST)[2] funded by the National Institutes of Health (NIH.)
Indications
The aim of CAS is to prevent the adverse sequelae of carotid artery stenosis secondary to atherosclerotic disease, i.e. stroke.
Carotid stenting is currently indicated for the following patients:
Either
- Symptomatic patients with >50% stenosis
OR
- Asymptomatic patients with >80% stenosis
AND
- At least one anatomic or co-morbid risk factor placing them at high-risk for adverse events from CEA:
- Anatomic Risk Factors:
- Contralateral carotid artery occlusion
- Contralateral laryngeal nerve palsy
- Scarring of the neck post radiation therapy or following neck surgery
- Recurrent stenosis after prior carotid surgery
- High cervical carotid artery lesions
- Carotid artery stenosis:
- Below the clavicle
- Distal to the second cervical vertebra
- Proximal (intrathoracic) arterial stenosis
- Previous carotid endarterectomy
- Contralateral vocal cord paralysis
- Open tracheostomy
- Co-Morbid Conditions:
- Congestive Heart Failure (Class III/IV), and/or known severe left ventricular dysfunction ≤30%
- Open-heart surgery needed within 6 weeks
- Recent myocardial infarction (>24 hours and <4 weeks)
- Unstable angina (CCS class III/IV)
- Synchronous severe cardiac and carotid disease requiring open heart surgery and carotid revascularization
- Severe pulmonary disease to include any of the following:
- Abnormal stress test
- Age greater than 80 years
Carotid Revascularization in Patients Undergoing CABG
Symptomatic Stenosis
CAS (with embolic protection) before or concurrent with CABG is reasonable in patients with >80% stenosis who have experienced ipsilateral retinal or hemispheric cerebral ischemic symptoms within 6 months (I,C).
Asymptomatic Stenosis
The safety and efficacy of carotid revascularization before or concurrent with myocardial revacularization are not well established (II b, C)[2].
Risk Stratification
High Risk Lesion Characteristics
- Evidence of intraluminal thrombus thought to increase the risk of plaque fragmentation and distal embolization
- Lesion(s) that may require more than two stents
- Very tortuous lesions
- Total occlusion of the target vessel
- Lesions of the ostium of the common carotid
- Highly calcified lesions resistant to balloon inflation
- Concurrent treatment of bilateral lesions
High Risk Access Characteristics
- Patients with known peripheral vascular, supra-aortic or internal carotid artery tortuosity that would preclude the use of catheter-based techniques.
- Patients in whom femoral or brachial access is not possible
High Risk Patient Characteristics
- Patients at low-to-moderate risk for adverse events from carotid endarterectomy.
- Patients experiencing acute ischemic neurologic stroke or who experienced a stroke within 48 hours.
- Patients with an intracranial mass lesion (i.e., abscess, tumor, or infection) or aneurysm (>9mm).
- Patients with arterio-venous malformations of the territory of the target carotid artery.
- Patients with coagulopathies.
- Patients with poor renal function, who, in the physician’s opinion, may be at high-risk for a reaction to contrast medium.
- Patients with perforated vessels evidenced by extravasation of contrast media.
- Patients with aneurysmal dilation immediately proximal or distal to the lesion.
- Pregnant patients or patients under the age of 18.
Stenting (CAS) vs Carotid Endarterectomy (CEA)
Outcomes
- The CREST study showed a higher rate of death/MI in patients treated with stenting vs CEA: 6.4% vs 4.7%.
Scenarios Where Carotid Endarterectomy is Preferred
Carotid endarterectomy is preferred in the setting of:
- Impaired renal function with increased risk of contrast induced nephropathy
- A tortuous calcified aortoa
- Complex, eccentric, calcified lesions
Scenarios Where Carotid Endarterectomy is Preferred
Carotid endarterectomy is preferred in the setting of:
- Neck anatomy unfavorable for arterial surgery(II a, B)
- High carotid bifurcations where it is hard for surgeons to technically perform the surgery.
- Arterial stenosis distal to the second cervical vertebra or proximal (intrathoracic) arterial stenosis
- Previous ipsilateral carotid endarterectomy CEA
- Contralateral vocal cord paralysis
- Open tracheostomy
- History of previous radical neck surgery
- History of radiation therapy[2]
- Shown below is a table comparing carotid endarterectomy versus stenting in symptomatic and asymptomatic patients
- [2]
| Symptomatic Patients | Asymptomatic Patients | ||
| 50-69% Stenosis | 70-99% Stenosis | 70-99% Stenosis | |
| Endarterectomy | Class I | Class I | Class II a |
| LOE | B | A | A |
| Stenting | Class I | Class I | Class II b |
| LOE | B | B | B |
Procedure
- Informed consent obtained and local anaesthetic administered
- Preparation of both groins with antiseptic and draped
- Puncture into femoral artery and access through short sheath
- Guidewire passed through aorta and into arch
- Arch aortogram obtained if not previously performed to confirm suitability to continue
- Carotid and cerebral angiogram performed
- Long access sheath placed after cannulation of common carotid artery (CCA)
- Guidewire passed through area of carotid narrowing
- Placement of embolic protection device above the area of narrowing
- Angioplasty of carotid narrowing, but more commonly proceed straight to deployment of stent into area of narrowing
- Angioplasty post stent deployment
- Removal of protection device, guidewires and sheath
- Aftercare of groin puncture site